Market Research Report
Bioelectronic Medicine 2017-2027
|Published by||IDTechEx Ltd.||Product code||554911|
|Published||Content info||224 Slides
Delivery time: 1-2 business days
Bioelectronic Medicine 2017-2027
Cardiac Rhythm and Nerve Stimulator Devices, the Electric Future of Medicine.
Bioelectronic medicines hold the potential to change the way in which chronic diseases/ conditions are treated. Instead of taking a molecular medication (pharmaceutical), a tiny implantable electronic device will be the medication. Such device will use electrical stimulation as its form of therapy, presently, bioelectronic medicines are amongst us today they primarily treat cardiovascular diseases, neurological diseases and neurological conditions (chronic pain). In the future, bioelectronic medicines will be smaller, more sophisticated and will treat all known chronic diseases/ conditions known to man, these can be termed 'next generation' bioelectronic medicines.
More precisely, next generation bioelectronic medicines are expected to be the size of a grain of rice, they will be attached to a nerve within the peripheral nervous system that is implicated in a disease or disorder. They will function to change or restore faulty electrical signals in such nerve which will restore the proper function of the 'disordered' organ. Essentially, next generation bioelectronic medicines will read and write the electrical signals within the nervous system, they then will not only be therapeutics but sensors as well. Key drivers for this field are an aging population, an increase in chronic disease and an unmet need that current medical standards of care (pharmaceuticals, physical therapy, etc) have not met. The current market value for bioelectronic medicine is an estimated 15 B USD, this number will conservatively increase in the up and coming years.
While this market is saturated, efforts in the continuation of bioelectronic medicines have offered a plethora of opportunities for new entrants. Next generation bioelectronic medicines are currently in development, meaning no true next generation bioelectronic medicine has hit the market as of now. Researchers, as well as some start-up companies, are heavily invested in their development; the materials, design and functional capabilities needed to fabricate these sophisticated next generation bioelectronic medicines are being brainstormed. Therefore, researchers and pivotal players in this field are open to innovative ideas regarding materials, design and functionality of these devices.
In this report, a 10-year forecast is given, the key players in present day and future bioelectronic medicines are identified and targeted. The report is inclusive of the worldwide potential with the united states leading the way. Research methods were inclusive of attending pertinent conferences related to this topic, patent searches, scoping through annual reports, speaking to experts within this field as well as interviewing relevant companies within this realm.
All report purchases include up to 30 minutes telephone time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.